Molecular pathology is a rapidly growing area of anatomic pathology that analyzes genetic and molecular changes in tissues to guide diagnosis and treatment. By examining DNA, RNA, and proteins in tissue samples, molecular pathologists can identify mutations, gene expression patterns, and other biomarkers that inform precision medicine. This capability is transforming cancer care, where treatment increasingly depends on the molecular characteristics of a tumor.
Molecular pathology tests include sequencing, fluorescence in situ hybridization, immunohistochemistry, and polymerase chain reaction. These tests can identify mutations that predict response to targeted therapies, detect inherited cancer syndromes, and monitor treatment response. In some cases, molecular testing is essential for diagnosis, such as distinguishing between cancer types with similar appearance but different molecular profiles. The complexity of these tests requires specialized equipment, expertise, and quality control, driving demand for molecular pathology products and services. The Anatomic Pathology Market benefits from this growth, with molecular pathology representing an expanding segment.
The integration of molecular pathology into routine practice is expanding. As targeted therapies proliferate and companion diagnostics become more common, demand for molecular testing grows. Challenges include cost, access, reimbursement, and the need for education and infrastructure. As technology improves and costs decline, molecular pathology is likely to become more accessible, supporting precision medicine and improving outcomes for patients with cancer and other diseases.
People Also Ask
What is molecular pathology?
It is the analysis of genetic and molecular changes in tissues to guide diagnosis and treatment, supporting precision medicine in cancer and other diseases.
How does molecular pathology support precision medicine?
By identifying mutations and biomarkers, it helps select targeted therapies, predict treatment response, and personalize care based on a patient's molecular profile.
Tags: #MolecularPathology #PrecisionMedicine #CancerDiagnostics #Biomarkers #GenomicTesting #AnatomicPathology